Development, characterisation and nasal deposition of melatonin-loaded pectin/hypromellose microspheres.
暂无分享,去创建一个
K. Winnicka | M. Gretić | M. Jug | Marta Szekalska | Joanna Potaś | A. Hafner | Laura Nižić | Ivan Erak
[1] A. Mahmoud,et al. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension. , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[2] D. Spoljaric,et al. Innovative sprayable in situ gelling fluticasone suspension: Development and optimization of nasal deposition , 2019, International journal of pharmaceutics.
[3] Ariel D. Quiroga,et al. Chitosan-hydroxypropyl methylcellulose tioconazole films: A promising alternative dosage form for the treatment of vaginal candidiasis. , 2019, International journal of pharmaceutics.
[4] M. Wesołowski,et al. Interactions Between Paracetamol and Hypromellose in the Solid State , 2019, Front. Pharmacol..
[5] K. Winnicka,et al. Spray-dried nanoparticle-loaded pectin microspheres for dexamethasone nasal delivery , 2019, Drying Technology.
[6] Xiuhua Zhao,et al. Preparation, characterization and in vitro evaluation of melatonin-loaded porous starch for enhanced bioavailability. , 2018, Carbohydrate polymers.
[7] R. Reiter,et al. The multiple functions of melatonin in regenerative medicine , 2018, Ageing Research Reviews.
[8] C. Kiparissides,et al. Recent advances in carrier mediated nose‐to‐brain delivery of pharmaceutics , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[9] Daniel A. Davis,et al. Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts. , 2018, Molecular pharmaceutics.
[10] Ivan Pepić,et al. An overview of in vitro dissolution/release methods for novel mucosal drug delivery systems , 2018, Journal of pharmaceutical and biomedical analysis.
[11] E. Zironi,et al. In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates , 2018, Drug delivery.
[12] Mengrui Liu,et al. Progress in brain targeting drug delivery system by nasal route , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[13] J. Lovrić,et al. Lipid/alginate nanoparticle-loaded in situ gelling system tailored for dexamethasone nasal delivery. , 2017, International journal of pharmaceutics.
[14] A. H. Salama,et al. Reconstitutable spray dried ultra-fine dispersion as a robust platform for effective oral delivery of an antihyperlipidemic drug. , 2017, International journal of pharmaceutics.
[15] P. Russo,et al. Opportunity and challenges of nasal powders: Drug formulation and delivery , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[16] Edyta Pindelska,et al. Pharmaceutical cocrystals, salts and polymorphs: Advanced characterization techniques , 2017, Advanced drug delivery reviews.
[17] J. Lulek,et al. The wettability and swelling of selected mucoadhesive polymers in simulated saliva and vaginal fluids. , 2017, Colloids and surfaces. B, Biointerfaces.
[18] F. Pirot,et al. Formulation, stability testing, and analytical characterization of melatonin-based preparation for clinical trial , 2017, Journal of pharmaceutical analysis.
[19] O. Chambin,et al. Pellets based on polyuronates: Relationship between gelation and release properties , 2017 .
[20] H. Katsumi,et al. Nasal Drug Absorption from Powder Formulations: Effect of Fluid Volume Changes on the Mucosal Surface. , 2017, Biological & pharmaceutical bulletin.
[21] M. Klarić,et al. Melatonin-loaded chitosan/Pluronic® F127 microspheres as in situ forming hydrogel: An innovative antimicrobial wound dressing. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[22] R. Scherließ,et al. Carrier-based dry powder formulation for nasal delivery of vaccines utilizing BSA as model drug , 2016 .
[23] P. Giunchedi,et al. Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review , 2016 .
[24] M. Gümüşderelioğlu,et al. Melatonin/HPβCD complex: Microwave synthesis, integration with chitosan scaffolds and inhibitory effects on MG-63CELLS. , 2015, International journal of pharmaceutics.
[25] P. Mura. Analytical techniques for characterization of cyclodextrin complexes in the solid state: A review. , 2015, Journal of pharmaceutical and biomedical analysis.
[26] J. Rosenberg,et al. Clinical pharmacokinetics of melatonin: a systematic review , 2015, European Journal of Clinical Pharmacology.
[27] P. Cooke,et al. Characterization of the global structure of low methoxyl pectin in solution , 2015 .
[28] S. Verma,et al. Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug , 2015, AAPS PharmSciTech.
[29] R. Chadha,et al. Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques. , 2014, Journal of pharmaceutical and biomedical analysis.
[30] I. Kosalec,et al. Development of low methoxy amidated pectin-based mucoadhesive patches for buccal delivery of triclosan: effect of cyclodextrin complexation. , 2012, Carbohydrate polymers.
[31] P. Djupesland. Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review , 2012, Drug Delivery and Translational Research.
[32] M. Šegvić Klarić,et al. Mupirocin calcium microencapsulation via spray drying: feed solvent influence on microparticle properties, stability and antimicrobial activity , 2011, Drug development and industrial pharmacy.
[33] Mandip Singh,et al. Nose-to-brain transport of melatonin from polymer gel suspensions: a microdialysis study in rats , 2011, Journal of drug targeting.
[34] Bo Nyström,et al. Characterization of polyelectrolyte features in polysaccharide systems and mucin. , 2010, Advances in colloid and interface science.
[35] Liang Tang,et al. The application of mucoadhesive polymers in nasal drug delivery , 2010 .
[36] D. Voinovich,et al. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers. , 2009, International journal of pharmaceutics.
[37] P. Watts,et al. PecSys: in situ gelling system for optimised nasal drug delivery , 2009 .
[38] T. Purewal,et al. Development and testing of particulate formulations for the nasal delivery of antibodies. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[39] M. Deli,et al. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. , 2009, Biochimica et biophysica acta.
[40] M. Jug,et al. Development of a Cyclodextrin-Based Nasal Delivery System for Lorazepam , 2008 .
[41] A. Mauro,et al. Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems. , 2007, Journal of nanoscience and nanotechnology.
[42] J. Nunthanid,et al. Mucoadhesive properties of various pectins on gastrointestinal mucosa: an in vitro evaluation using texture analyzer. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[43] A. Bansal,et al. Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids. , 2006, Journal of pharmaceutical sciences.
[44] D. Durand,et al. Calcium and acid induced gelation of (amidated) low methoxyl pectin , 2006 .
[45] Valentina Iannuccelli,et al. Enhancement of melatonin photostability by encapsulation in lipospheres. , 2006, Journal of pharmaceutical and biomedical analysis.
[46] R. Kinget,et al. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. , 2005, Advanced drug delivery reviews.
[47] M. Tafaghodi,et al. Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy. , 2004, International journal of pharmaceutics.
[48] O. Corrigan,et al. Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices--influence of agitation rate and dissolution medium composition. , 2004, International journal of pharmaceutics.
[49] M. Bogataj,et al. The correlation between zeta potential and mucoadhesion strength on pig vesical mucosa. , 2003, Biological & pharmaceutical bulletin.
[50] M. R. Bailey,et al. The influence of breathing patterns on particle deposition in a nasal replicate cast , 2002 .
[51] S. Davis,et al. Clearance characteristics of chitosan based formulations in the sheep nasal cavity. , 2001, International journal of pharmaceutics.
[52] Lena Pereswetoff-Morath,et al. Microspheres as nasal drug delivery systems. , 1998, Advanced drug delivery reviews.
[53] Dimitrios G Fatouros,et al. Smart materials: in situ gel-forming systems for nasal delivery. , 2016, Drug discovery today.
[54] H. Leuenberger,et al. Preparation of dry powder inhalation by surface treatment of lactose carrier particles. , 2003, Chemical & pharmaceutical bulletin.